MMR Vaccine Injection for Advanced Pancreatic Cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether injecting an MMR (measles, mumps, rubella) vaccine directly into a pancreatic tumor can help your immune system fight the cancer. You're eligible if your pancreatic cancer cannot be surgically removed after standard chemotherapy and radiation treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Pancreatic cancer confirmed by biopsy that cannot be removed by surgery, even after chemotherapy and radiation
- Completed standard chemotherapy (like FOLFIRINOX or gemcitabine-based treatment) and radiation therapy 6–12 weeks before starting the study
- Good overall health status (able to carry out daily activities with minimal assistance)
- Blood counts and liver/kidney function within acceptable ranges
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving targeted radiation (SBRT) followed by an experimental immunotherapy drug injected directly into the tumor is safe for people with locally advanced pancreatic cancer. It aims to shrink the tumor and help your immune system fight it.
This trial tests a new tumor vaccine combined with a standard chemotherapy regimen (AG) for people with metastatic pancreatic cancer. It aims to see if the combination is safe and helps the immune system fight the cancer.
This trial tests a new type of MRI-guided radiation therapy for people with locally advanced pancreatic cancer that can't be removed by surgery. If you have already had 2 months of chemotherapy, or chose not to, this treatment might help control the tumor.
This trial tests a new radioactive injection called NRT6008 for people with pancreatic cancer that cannot be surgically removed. It aims to see if the treatment can shrink the tumor and improve survival.
This trial tests a new combination of treatments for people with advanced pancreatic cancer that has spread to the liver or lungs. It includes a cancer vaccine, two chemotherapy drugs, an immunotherapy drug, and a heat-based therapy to see if it can help shrink tumors and improve outcomes.
This trial tests a new mRNA vaccine (AK154) alone or with other immunotherapy drugs after successful pancreatic cancer surgery. It also looks at adding chemotherapy later. The goal is to see if this treatment can help prevent the cancer from coming back.
Hear when a new Borderline Resectable/Unresectable Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.